Harm H E van Melick

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study”.

Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study

European Urology Open Science(2024)10.1016/j.euros.2024.08.004

N/A

0DataRank · unranked

6 citations

Emily Vertosick, Roderick C.N. van den Bergh, Timo Soeterik, Joris G. Heetman, Harm H E van Melick +22 more

Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging–targeted prostate biopsy grade groups are discordant

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf275

N/A

0DataRank · unranked

1 citations

Targeted Biopsies Prostate Cancer Collaborative Group, Francesco Montorsi, Alberto Briganti, Armando Stabile, Amy L. Tin +57 more